Literature DB >> 20327519

Substitution for Brand-Name Drugs.

S Caminetsky.   

Abstract

Year:  1963        PMID: 20327519      PMCID: PMC1921271     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  BRAND NAMES OR PROPER NAMES?(THE QUESTION IN PERSPECTIVE).

Authors:  H D COOK
Journal:  Can Med Assoc J       Date:  1964-07-25       Impact factor: 8.262

2.  The bioavailability in man of marketed brands of chlorpropamide.

Authors:  A M Monro; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 3.  Drugs, drug products and prescribing habits.

Authors:  D N Wade
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  RATES OF DISSOLUTION OF TOLBUTAMIDE TABLETS.

Authors:  N BRUDNEY; D J STEWART; B T EUSTACE
Journal:  Can Med Assoc J       Date:  1964-04-18       Impact factor: 8.262

5.  A COMPARATIVE STUDY OF SOME BRANDS OF TOLBUTAMIDE AVAILABLE IN CANADA. II. PHARMACEUTICAL ASPECTS.

Authors:  F C LU; W B RICE; C W MAINVILLE
Journal:  Can Med Assoc J       Date:  1965-05-29       Impact factor: 8.262

6.  A COMPARATIVE STUDY OF SOME BRANDS OF TOLBUTAMIDE AVAILABLE IN CANADA. I. CLINICAL ASPECTS.

Authors:  J B MCKENDRY; F C LU; D BICKERTON; G HANCHARYK
Journal:  Can Med Assoc J       Date:  1965-05-22       Impact factor: 8.262

7.  EFFECT OF DOSAGE FORM PROPERTIES ON THERAPEUTIC EFFICACY OF TOLBUTAMIDE TABLETS.

Authors:  G LEVY
Journal:  Can Med Assoc J       Date:  1964-04-18       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.